A
Allan E. Rubenstein
Researcher at Icahn School of Medicine at Mount Sinai
Publications - 17
Citations - 2860
Allan E. Rubenstein is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Neurofibromatosis & Locus (genetics). The author has an hindex of 12, co-authored 17 publications receiving 2786 citations. Previous affiliations of Allan E. Rubenstein include House Ear Institute.
Papers
More filters
Journal ArticleDOI
The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2.
David H. Gutmann,Arthur S. Aylsworth,John C. Carey,Bruce R. Korf,Joan Marks,Reed E. Pyeritz,Allan E. Rubenstein,David Viskochil +7 more
TL;DR: The diagnostic criteria for neurofibromatosis 1 and neurof fibromaatosis 2, recommendations for the care of patients and their families at diagnosis and during routine follow-up, and the role of DNA diagnostic testing in the evaluation of these disorders are determined.
Journal ArticleDOI
Von Hippel–Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma
Bernd R. Seizinger,Guy A. Rouleau,Laurie J. Ozelius,A.H. Lane,G. E. Farmer,J M Lamiell,Jonathan Haines,J. W M Yuen,D. Collins,Danielle Majoor-Krakauer,Tom I. Bonner,Christopher G. Mathew,Allan E. Rubenstein,John J. Halperin,Allyn McConkie-Rosell,Jane Green,James A. Trofatter,Bruce A.J. Ponder,L. Eierman,M. I. Bowmer,R. Schimke,Ben A. Oostra,Neil Aronin,David I. Smith,Harry A. Drabkin,M. H. Waziri,Wendy Hobbs,Robert L. Martuza,P. M. Conneally,Y. E. Hsia,James F. Gusella +30 more
TL;DR: The VHL gene is linked to the locus encoding the human homologoue of the RAF1 oncogene, which maps to chromosome 3p25 (ref. 4), which suggests that the defect responsible for the VHL phenotype is not a mutation in the RAF 1 gene itself.
Journal ArticleDOI
The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2
Arthur S. Aylsworth,John C. Carey,Bruce R. Korf,J Marks,Reed E. Pyeritz,Allan E. Rubenstein,Dave Viskochil,David H. Gutmann +7 more
TL;DR: The diagnostic criteria for neurofibromatosis 1 and neurof fibromaatosis 2, recommendations for the care of patients and their families at diagnosis and during routine follow-up, and the role of DNA diagnostic testing in the evaluation of these disorders are determined.
Journal Article
Deletions spanning the neurofibromatosis 1 gene: identification and phenotype of five patients.
Lucille M. Kayes,Wylie Burke,Vincent M. Riccardi,Robin L. Bennett,Pamela Ehrlich,Allan E. Rubenstein,Karen Stephens +6 more
TL;DR: All five patients with deletions were remarkable for exhibiting a large number of neurofibromas for their age, suggesting that deletion of an unknown gene in the NF1 region may affect tumor initiation or development.
Journal ArticleDOI
Consensus Recommendations to Accelerate Clinical Trials for Neurofibromatosis Type 2
D. Gareth Evans,Michel Kalamarides,Kim Hunter-Schaedle,Jaishri O. Blakeley,Jeffrey C. Allen,Dusica Babovic-Vuskanovic,Allan J. Belzberg,Gideon Bollag,Ruihong Chen,Emmanuelle diTomaso,John G. Golfinos,Gordon J. Harris,Abraham Jacob,Ganjam V. Kalpana,Matthias A. Karajannis,Bruce R. Korf,Razelle Kurzrock,Meng Law,Andrea I. McClatchey,Roger J. Packer,Pamela C. Roehm,Allan E. Rubenstein,William H. Slattery,James H. Tonsgard,D. Bradley Welling,Brigitte C. Widemann,Kaleb Yohay,Marco Giovannini +27 more
TL;DR: Recommendations are provided from a workshop, cochaired by Drs.